(Q40325540)

19 September 2017

Heparan sulfate plays a central role in a dynamic in vitro model of protein-losing enteropathy (English)

1 reference

19 September 2017

3

1 reference

19 September 2017

Lars Bode

1

1 reference

PubMed ID

16434407

19 September 2017

Simon Murch

series ordinal

2

1 reference

PubMed ID

16434407

19 September 2017

language of work or name

English

0 references

publication date

24 January 2006

1 reference

Journal of Biological Chemistry

19 September 2017

1 reference

19 September 2017

281

1 reference

19 September 2017

12

1 reference

19 September 2017

7809-7815

1 reference

Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation

19 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Gastrointestinal manifestations of postnatal cytomegalovirus infection in infants admitted to a neonatal intensive care unit over a five year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Outcomes after the Fontan procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Modulation of barrier function of small intestinal epithelial cells by lamina propria fibroblasts in response to lipopolysaccharide: possible role in TNFalpha in inducing barrier dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Heparan sulfate depletion amplifies TNF-alpha-induced protein leakage in an in vitro model of protein-losing enteropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Strategies to treat protein-losing enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Heparin therapy for ulcerative colitis? Effects and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

The antagonism of interferon-gamma (IFN-gamma) by heparin: examination of the blockade of class II MHC antigen and heat shock protein-70 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Reversal of protein-losing enteropathy in a child with Fontan circulation is correlated with central venous pressure after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Heparin modulates the growth and adherence and augments the growth-inhibitory action of TNF-alpha on cultured human keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

A proteoglycan undergoes different modifications en route to the apical and basolateral surfaces of Madin-Darby canine kidney cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

Disruption of sulphated glycosaminoglycans in intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M510722200

21 January 2018

Identifiers

DOI

10.1074/JBC.M510722200

1 reference

19 September 2017

1 reference

PubMed ID

16434407